CVFG LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Sell
16,337
-567
-3% -$579K 2.06% 7
2026
Q1
$15.5M Buy
16,904
+13,075
+341% +$13.3M 1.93% 7
2025
Q4
$4.11M Sell
3,829
-636
-14% -$608K 2.82% 11
2025
Q3
$3.41M Buy
4,465
+187
+4% +$139K 2.46% 13
2025
Q2
$3.34M Buy
4,278
+60
+1% +$46.6K 2.65% 12
2025
Q1
$3.48M Sell
4,218
-377
-8% -$314K 3.17% 9
2024
Q4
$3.55M Buy
+4,595
New +$3.8M 3.24% 9

Other funds holding LLY

CVFG LLC's LLY Position: Q2 2026 in Review

CVFG LLC reduced its Eli Lilly (LLY) stake by 3.4% in Q2 2026, selling an estimated $579K and leaving 16,337 shares worth $19.6M. The position accounts for 2.06% of the portfolio, ranked #7.

CVFG LLC first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CVFG LLC held 16,337 shares of Eli Lilly worth $19.6M as of Q2 2026.
  • CVFG LLC sold 567 Eli Lilly shares in Q2 2026, an estimated $579K.
  • Eli Lilly made up 2.06% of CVFG LLC's portfolio in Q2 2026, its #7 holding.
  • CVFG LLC first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CVFG LLC's 13F filing for Q2 2026, filed 11 Aug 2026.